You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
| Record Information |
|---|
| Version | 3.6 |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2017-03-02 21:25:35 UTC |
|---|
| HMDB ID | HMDB00042 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Acetic acid |
|---|
| Description | Acetic acid is one of the simplest carboxylic acids. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted by certain bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil, and acetic acid is produced naturally as fruits and some other foods spoil. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Acide acetique | ChEBI | | AcOH | ChEBI | | CH3-COOH | ChEBI | | CH3CO2H | ChEBI | | e 260 | ChEBI | | e-260 | ChEBI | | e260 | ChEBI | | Essigsaeure | ChEBI | | Ethanoic acid | ChEBI | | Ethoic acid | ChEBI | | Ethylic acid | ChEBI | | HOAc | ChEBI | | INS no. 260 | ChEBI | | MeCO2h | ChEBI | | MeCOOH | ChEBI | | Methanecarboxylic acid | ChEBI | | Acetate | Generator | | Ethanoate | Generator | | Ethoate | Generator | | Ethylate | Generator | | Methanecarboxylate | Generator | | Glacial acetate | HMDB | | Glacial acetic acid | HMDB | | Kyselina octova | HMDB | | Vinegar | HMDB | | Vinegar acid | HMDB | | Acid, acetic | MeSH | | Acetic acid glacial | MeSH | | Acid glacial, acetic | MeSH | | Acid, glacial acetic | MeSH | | Acetic acid, glacial | MeSH | | Glacial, acetic acid | MeSH |
|
|---|
| Chemical Formula | C2H4O2 |
|---|
| Average Molecular Weight | 60.052 |
|---|
| Monoisotopic Molecular Weight | 60.021129372 |
|---|
| IUPAC Name | acetic acid |
|---|
| Traditional Name | acetic acid |
|---|
| CAS Registry Number | 64-19-7 |
|---|
| SMILES | CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4) |
|---|
| InChI Key | QTBSBXVTEAMEQO-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as carboxylic acids. These are compounds containing a carboxylic acid group with the formula -C(=O)OH. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Carboxylic acids |
|---|
| Direct Parent | Carboxylic acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Status | Detected and Quantified |
|---|
| Origin | |
|---|
| Biofunction | - Component of Glycerophospholipid metabolism
- Component of Propanoate metabolism
- Component of Pyruvate metabolism
- Waste products
|
|---|
| Application | Not Available |
|---|
| Cellular locations | - Cytoplasm
- Extracellular
- Mitochondria
- Golgi apparatus
|
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | 16.6 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 1000.0 mg/mL | Not Available | | LogP | -0.17 | HANSCH,C ET AL. (1995) |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS | Not Available |
|---|
| GC-MS | GC-MS Spectrum - EI-B | splash10-0007-9000000000-a9a21f72ec25efbc1650 | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-03di-9000000000-044b361cb9f5775c43fe | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-01ox-9000000000-6437eb5f6a38c054dc37 | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-0006-9000000000-0505dfa8ee07a18a3ef3 | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - EI-B (HITACHI M-80B) , Positive | splash10-0007-9000000000-a0d65dd4e056c1482aaa | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-0a4i-9000000000-a845ea0157abb3d7783b | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-0a4i-9000000000-42ec023f024176a1c692 | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-0a4i-9000000000-2bbab52cd9d076b89b2c | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-0a4i-9000000000-fb6d2f6298dd5bc37c2e | View in MoNA |
|---|
| LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-0a4i-9000000000-bc47c47ade16451259c7 | View in MoNA |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | Not Available |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | Not Available |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | Not Available |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | Not Available |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | Not Available |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | Not Available |
|---|
| MS | Mass Spectrum (Electron Ionization) | splash10-01oy-9000000000-181ada67a3e5798d4419 | View in MoNA |
|---|
| 1D NMR | 1H NMR Spectrum | Not Available |
|---|
| 1D NMR | 13C NMR Spectrum | Not Available |
|---|
| 1D NMR | 1H NMR Spectrum | Not Available |
|---|
| 1D NMR | 13C NMR Spectrum | Not Available |
|---|
| 1D NMR | 1H NMR Spectrum | Not Available |
|---|
| 2D NMR | [1H,1H] 2D NMR Spectrum | Not Available |
|---|
| 2D NMR | [1H,13C] 2D NMR Spectrum | Not Available |
|---|
|
|---|
| Biological Properties |
|---|
| Cellular Locations | - Cytoplasm
- Extracellular
- Mitochondria
- Golgi apparatus
|
|---|
| Biofluid Locations | - Blood
- Breast Milk
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
|---|
| Tissue Location | - Kidney
- Liver
- Most Tissues
|
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Amino Sugar Metabolism | SMP00045 | map00520 | | Aspartate Metabolism | SMP00067 | map00250 | | Canavan Disease | SMP00175 | Not Available | | Disulfiram Pathway | SMP00429 | Not Available | | Ethanol Degradation | SMP00449 | Not Available | | Fatty Acid Biosynthesis | SMP00456 | Not Available | | G(M2)-Gangliosidosis: Variant B, Tay-sachs disease | SMP00534 | Not Available | | Heroin Metabolism Pathway | SMP00623 | Not Available | | Heroin Pathway | SMP00407 | Not Available | | Hypoacetylaspartia | SMP00192 | Not Available | | Leigh Syndrome | SMP00196 | Not Available | | Primary hyperoxaluria II, PH2 | SMP00558 | Not Available | | Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) | SMP00334 | Not Available | | Pyruvate Dehydrogenase Complex Deficiency | SMP00212 | Not Available | | Pyruvate kinase deficiency | SMP00559 | Not Available | | Pyruvate Metabolism | SMP00060 | map00620 | | Salla Disease/Infantile Sialic Acid Storage Disease | SMP00240 | Not Available | | Sialuria or French Type Sialuria | SMP00216 | Not Available | | Sialuria or French Type Sialuria | SMP00217 | Not Available | | Tay-Sachs Disease | SMP00390 | Not Available |
|
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 30.4 (22.0-40.0) uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 41.9 +/- 15.1 uM | Adult (>18 years old) | Both | Normal | | details | | Breast Milk | Detected and Quantified | 27.5 +/- 28.2 uM | Adult (>18 years old) | Female | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 116.0 +/- 55.0 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 58.0 +/- 27.0 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 100.0 +/- 30.0 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 284.0 +/- 126.0 uM | Children (1-13 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Infant (0-1 year old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 35860 +/- 16800 nmol/g of feces | Adult (>18 years old) | Female | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Newborn (0-30 days old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 0 - 547.18 ppm | Children (1-13 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | | Not Specified | Not Specified | Normal | | details | | Saliva | Detected and Quantified | 10200 +/- 10200 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | | Adult (>18 years old) | Not Specified | Normal | | details | | Saliva | Detected and Quantified | 14640 +/- 13790 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 12650 +/- 12830 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 11350 +/- 12920 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 11220 +/- 10900 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | | Adult (>18 years old) | Not Specified | Normal | | details | | Saliva | Detected and Quantified | 12350 +/- 14040 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 10340 +/- 10640 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 6814.91 +/- 4310.71 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 433 (19-2749) uM | Adult (>18 years old) | Male | normal | | details | | Saliva | Detected and Quantified | 112 (5-726) uM | Adult (>18 years old) | Male | normal | | details | | Saliva | Detected and Quantified | 228 (19-1495) uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 323 (17-4048) uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 443 (80-2667) uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 185 (28-993) uM | Adult (>18 years old) | Female | Normal | | details | | Urine | Detected but not Quantified | | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.0 (2.5-106.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 3.31 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 16.064 +/- 11.375 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 45.33 +/- 53.33 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 42.2 +/- 17.3 uM | Adult (>18 years old) | Both | Heart Transplant | | details | | Blood | Detected but not Quantified | | Adult (>18 years old) | Both | Colorectal cancer | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 35.3 - 211.7 uM | Adult (>18 years old) | Not Specified | Multiple sclerosis | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Ulcerative colitis | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Campylobacter jejuni infection | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Clostridium difficile infection | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Ulcerative Colitis | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Irritable Bowel Syndrome | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Crohn’s Disease | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Ulcerative Colitis | | details | | Feces | Detected and Quantified | 0 - 778.62 ppm | Children (1-13 years old) | Not Specified | Treated celiac disease | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Nonalcoholic fatty liver disease (NAFLD) | | details | | Feces | Detected but not Quantified | | Adult (>18 years old) | Both | Colorectal cancer | | details | | Urine | Detected but not Quantified | | Adult (>18 years old) | Both | Breast cancer | | details | | Urine | Detected and Quantified | 53.0 +/- 71.0 umol/mmol creatinine | Not Specified | Both | Lung cancer | | details | | Urine | Detected and Quantified | 25.477 +/- 36.046 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | | Urine | Detected and Quantified | 23.7 +/- 4.5 umol/mmol creatinine | Adult (>18 years old) | Both | 3-Hydroxy-3- methylglutaryl-CoA lyase (HL) deficency | | details | | Urine | Detected and Quantified | 12.9 +/- 0 umol/mmol creatinine | Adult (>18 years old) | Both | 3-Hydroxy-3- methylglutaryl-CoA lyase (HL) deficency | | details | | Urine | Detected and Quantified | 54.1 +/- 23.8 umol/mmol creatinine | Adult (>18 years old) | Both | Argininosuccinic aciduria (ASL) | | details | | Urine | Detected and Quantified | 20.2 +/- 3.9 umol/mmol creatinine | Adult (>18 years old) | Both | Propionic acidemia | | details | | Urine | Detected and Quantified | 20.8 +/- 3 umol/mmol creatinine | Adult (>18 years old) | Both | Propionic acidemia | | details | | Urine | Detected and Quantified | 99.4 +/- 8.6 umol/mmol creatinine | Adult (>18 years old) | Both | Tyrosinemia I | | details | | Urine | Detected and Quantified | 16.3 +/- 7.1 umol/mmol creatinine | Adult (>18 years old) | Both | Phenylketonuria | | details | | Urine | Detected and Quantified | 375.3 +/- 6.3 umol/mmol creatinine | Adult (>18 years old) | Both | Phenylketonuria | | details | | Urine | Detected and Quantified | 13.2 +/- 5.5 umol/mmol creatinine | Adult (>18 years old) | Both | Maple syrup urine disease | | details | | Urine | Detected and Quantified | 21.8 +/- 0 umol/mmol creatinine | Adult (>18 years old) | Both | Aminoaciduria | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Lung Cancer |
|---|
- Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R, Baracos VE: Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr. 2012 Jan;142(1):14-21. doi: 10.3945/jn.111.147751. Epub 2011 Dec 7. [PubMed:22157537 ]
| | Multiple sclerosis |
|---|
- Lutz NW, Viola A, Malikova I, Confort-Gouny S, Audoin B, Ranjeva JP, Pelletier J, Cozzone PJ: Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid. PLoS One. 2007 Jul 4;2(7):e595. [PubMed:17611627 ]
|
|
|---|
| Associated OMIM IDs | |
|---|
| External Links |
|---|
| DrugBank ID | DB03166 |
|---|
| DrugBank Metabolite ID | DBMET00484 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| Phenol Explorer Metabolite ID | Not Available |
|---|
| FoodDB ID | FDB008299 |
|---|
| KNApSAcK ID | C00001176 |
|---|
| Chemspider ID | 171 |
|---|
| KEGG Compound ID | C00033 |
|---|
| BioCyc ID | ACET |
|---|
| BiGG ID | 33590 |
|---|
| Wikipedia Link | Acetic acid |
|---|
| NuGOwiki Link | HMDB00042 |
|---|
| Metagene Link | HMDB00042 |
|---|
| METLIN ID | 3206 |
|---|
| PubChem Compound | 176 |
|---|
| PDB ID | ACY |
|---|
| ChEBI ID | 15366 |
|---|
| References |
|---|
| Synthesis Reference | Law, David John. Process for the preparation of carboxylic acids and/or derivatives thereof. PCT Int. Appl. (2007), 14pp. |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811. [PubMed:7762816 ]
- Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7. [PubMed:12097436 ]
- Muniz-Junqueira MI, Braga Lopes C, Magalhaes CA, Schleicher CC, Veiga JP: Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Life Sci. 2005 Nov 4;77(25):3141-55. Epub 2005 Jul 11. [PubMed:16005905 ]
- Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006 Nov;244(5):706-14. [PubMed:17060763 ]
- Camoutsis C, Trafalis D, Pairas G, Papageorgiou A: On the formation of 4-[N,N-bis(2-chloroethyl)amino]phenyl acetic acid esters of hecogenin and aza-homo-hecogenin and their antileukemic activity. Farmaco. 2005 Oct;60(10):826-9. Epub 2005 Aug 31. [PubMed:16139280 ]
- Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25. [PubMed:15627241 ]
- Li M, Pan XL, Wang LL, Feng Y, Huang N, Wu Q, Li X, Wang BY: [Study of antmicrobial mechanisms of human cervical mucus: isolation and characterization of antibacterial polypeptides]. Zhonghua Yi Xue Za Zhi. 2005 Apr 27;85(16):1109-12. [PubMed:16029568 ]
- Vaca G, Hernandez A, Ibarra B, Velazquez A, Olivares N, Sanchez-Corona J, Medina C, Cantu JM: Detection of inborn errors of metabolism in 1,117 patients studied because of suspected inherited disease. Arch Invest Med (Mex). 1981;12(3):341-8. [PubMed:7294941 ]
- Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA: 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed. 1991 Aug;4(4):192-200. [PubMed:1931558 ]
- Yagi K, Nakamura A, Sekine A: [Magnification endoscopy diagnosis of Barrett's esophagus with methylene blue and acetic acid]. Nihon Rinsho. 2005 Aug;63(8):1411-5. [PubMed:16101231 ]
- Fan DD, Luo Y, Mi Y, Ma XX, Shang L: Characteristics of fed-batch cultures of recombinant Escherichia coli containing human-like collagen cDNA at different specific growth rates. Biotechnol Lett. 2005 Jun;27(12):865-70. [PubMed:16086249 ]
- Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lorincz A, Dores GB, Costa S, Syrjanen S: Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res. 2005 Sep-Oct;25(5):3469-80. [PubMed:16101165 ]
- Yri OE, Bjoro T, Fossa SD: Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol. 2006 Jan;49(1):54-8; discussion 58. Epub 2005 Nov 15. [PubMed:16314038 ]
- eMedicine [Link]
|
|---|